These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12695854)

  • 1. A novel polyamine analog (SL-11093) inhibits growth of human prostate tumor xenografts in nude mice.
    Frydman B; Porter CW; Maxuitenko Y; Sarkar A; Bhattacharya S; Valasinas A; Reddy VK; Kisiel N; Marton LJ; Basu HS
    Cancer Chemother Pharmacol; 2003 Jun; 51(6):488-92. PubMed ID: 12695854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopropane-containing polyamine analogues are efficient growth inhibitors of a human prostate tumor xenograft in nude mice.
    Frydman B; Blokhin AV; Brummel S; Wilding G; Maxuitenko Y; Sarkar A; Bhattacharya S; Church D; Reddy VK; Kink JA; Marton LJ; Valasinas A; Basu HS
    J Med Chem; 2003 Oct; 46(21):4586-600. PubMed ID: 14521420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action.
    Porter CW; Bernacki RJ; Miller J; Bergeron RJ
    Cancer Res; 1993 Feb; 53(3):581-6. PubMed ID: 8425191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane.
    Igarashi K; Koga K; He Y; Shimogori T; Ekimoto H; Kashiwagi K; Shirahata A
    Cancer Res; 1995 Jun; 55(12):2615-9. PubMed ID: 7780977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of the polyamine analog N(1), N(11)-diethylnorspermine against human prostate carcinoma cells.
    Schipper RG; Deli G; Deloyer P; Lange WP; Schalken JA; Verhofstad AA
    Prostate; 2000 Sep; 44(4):313-21. PubMed ID: 10951496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel lysine-spermine conjugate inhibits polyamine transport and inhibits cell growth when given with DFMO.
    Weeks RS; Vanderwerf SM; Carlson CL; Burns MR; O'Day CL; Cai F; Devens BH; Webb HK
    Exp Cell Res; 2000 Nov; 261(1):293-302. PubMed ID: 11082299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo.
    Srivastava SK; Xiao D; Lew KL; Hershberger P; Kokkinakis DM; Johnson CS; Trump DL; Singh SV
    Carcinogenesis; 2003 Oct; 24(10):1665-70. PubMed ID: 12896904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
    Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
    Samsel L; Zaidel G; Drumgoole HM; Jelovac D; Drachenberg C; Rhee JG; Brodie AM; Bielawska A; Smyth MJ
    Prostate; 2004 Mar; 58(4):382-93. PubMed ID: 14968439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction.
    Xiao D; Lew KL; Kim YA; Zeng Y; Hahm ER; Dhir R; Singh SV
    Clin Cancer Res; 2006 Nov; 12(22):6836-43. PubMed ID: 17121905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions.
    Chu Q; Lee DT; Tsao SW; Wang X; Wong YC
    BJU Int; 2007 Apr; 99(4):925-32. PubMed ID: 17155983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of advanced human prostate tumor growth in athymic mice by silibinin feeding is associated with reduced cell proliferation, increased apoptosis, and inhibition of angiogenesis.
    Singh RP; Sharma G; Dhanalakshmi S; Agarwal C; Agarwal R
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):933-9. PubMed ID: 14504208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
    Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.
    Ng SS; MacPherson GR; Gütschow M; Eger K; Figg WD
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4192-7. PubMed ID: 15217957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice.
    Khor TO; Keum YS; Lin W; Kim JH; Hu R; Shen G; Xu C; Gopalakrishnan A; Reddy B; Zheng X; Conney AH; Kong AN
    Cancer Res; 2006 Jan; 66(2):613-21. PubMed ID: 16423986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical antitumor activity of the oral platinum analog satraplatin.
    Wosikowski K; Lamphere L; Unteregger G; Jung V; Kaplan F; Xu JP; Rattel B; Caligiuri M
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):589-600. PubMed ID: 17541592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of human gastric adenocarcinoma xenograft growth in nude mice by alpha-difluoromethylornithine.
    Upp JR; Beauchamp RD; Townsend CM; Barranco SC; Singh P; Rajaraman S; James E; Thompson JC
    Cancer Res; 1988 Jun; 48(11):3265-9. PubMed ID: 3130188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer.
    Darnowski JW; Goulette FA; Cousens LP; Chatterjee D; Calabresi P
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):249-58. PubMed ID: 15173956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of experimental DU-145 prostate cancers with targeted cytotoxic somatostatin analog AN-238.
    Plonowski A; Schally AV; Nagy A; Sun B; Halmos G
    Int J Oncol; 2002 Feb; 20(2):397-402. PubMed ID: 11788908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the therapeutic and toxicological effects of cesium chloride following administration to nude mice bearing PC-3 or LNCaP prostate cancer xenografts.
    Low JC; Wasan KM; Fazli L; Eberding A; Adomat H; Guns ES
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):821-9. PubMed ID: 17294190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.